These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7922706)

  • 21. Immunoreactive thymosin alpha 1 is associated with murine T-cell lymphomas.
    Zatz MM; McClure JE; Goldstein AL
    Leuk Res; 1984; 8(6):1003-10. PubMed ID: 6096635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroELISA method for measurement of human serum thymosin alpha 1.
    Weller FE; Mutchnick MG; Keren DF; Goldstein AL; Naylor PH
    J Immunol Methods; 1985 Jun; 80(1):45-53. PubMed ID: 3891860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymalfasin: an immune system enhancer for the treatment of liver disease.
    Sjogren MH
    J Gastroenterol Hepatol; 2004 Dec; 19 Suppl 6():S69-72. PubMed ID: 15546253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune Modulation with Thymosin Alpha 1 Treatment.
    King R; Tuthill C
    Vitam Horm; 2016; 102():151-78. PubMed ID: 27450734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating thymulin and thymosin-alpha 1 activity in pediatric acquired immune deficiency syndrome: in vivo and in vitro studies.
    Rubinstein A; Novick BE; Sicklick MJ; Bernstein LJ; Incefy GS; Naylor PH; Goldstein AL
    J Pediatr; 1986 Sep; 109(3):422-7. PubMed ID: 3018210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmentation of influenza antibody response in elderly men by thymosin alpha one. A double-blind placebo-controlled clinical study.
    Gravenstein S; Duthie EH; Miller BA; Roecker E; Drinka P; Prathipati K; Ershler WB
    J Am Geriatr Soc; 1989 Jan; 37(1):1-8. PubMed ID: 2642497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The thymosins--preclinical and clinical studies with fraction V and alpha-I.
    Smalley RV; Talmadge J; Oldham RK; Thurman GB
    Cancer Treat Rev; 1984 Mar; 11(1):69-84. PubMed ID: 6234058
    [No Abstract]   [Full Text] [Related]  

  • 28. Modulatory role of thymosin-alpha-1 in normal bone-marrow haematopoiesis and its effect on myelosuppression in T-cell lymphoma bearing mice.
    Paul S; Sodhi A
    Immunol Lett; 2002 Jul; 82(3):171-82. PubMed ID: 12036599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice.
    Mastino A; Favalli C; Grelli S; Innocenti F; Garaci E
    Cell Immunol; 1991 Mar; 133(1):196-205. PubMed ID: 1991327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes.
    Leichtling KD; Serrate SA; Sztein MB
    Int J Immunopharmacol; 1990; 12(1):19-29. PubMed ID: 2303316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice.
    Mastino A; Favalli C; Grelli S; Rasi G; Pica F; Goldstein AL; Garaci E
    Int J Cancer; 1992 Feb; 50(3):493-9. PubMed ID: 1735618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy.
    Chadwick D; Pido-Lopez J; Pires A; Imami N; Gotch F; Villacian JS; Ravindran S; Paton NI
    Clin Exp Immunol; 2003 Dec; 134(3):477-81. PubMed ID: 14632754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II trial of thymosin fraction 5 and thymosin alpha 1.
    Dillman RO; Beauregard J; Royston I; Zavanelli MI
    J Biol Response Mod; 1987 Jun; 6(3):263-7. PubMed ID: 3598602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy with natural interleukins and/or thymosin alpha 1 potently augments T-lymphocyte responses of hydrocortisone-treated aged mice.
    Hadden JW; Saha A; Sosa M; Hadden EM
    Int J Immunopharmacol; 1995 Oct; 17(10):821-8. PubMed ID: 8707447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymosin alpha1. SciClone Pharmaceuticals.
    Billich A
    Curr Opin Investig Drugs; 2002 May; 3(5):698-707. PubMed ID: 12090542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of synthetic thymosin-alpha 1 and its analogs on fertilizability of human sperm: search for a biologically active, stable epitope.
    Naz RK; Kaplan P; Badamchian M; Goldstein AL
    Arch Androl; 1995; 35(1):63-9. PubMed ID: 8554434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymosin alpha 1-induced modulation of cellular responses and functional T-cell subsets in mice with experimental autoimmune thyroiditis.
    Tomazic VJ; Novotny EA; Ordonez JV
    Cell Immunol; 1985 Jul; 93(2):340-9. PubMed ID: 3873993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of thymic peptide thymosin alpha 1 with VIP receptors in rat intestinal epithelial cells: comparison with PHI and secretin.
    Calvo JR; Guerrero JM; Goberna R
    Gen Pharmacol; 1989; 20(4):503-5. PubMed ID: 2546855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of bioactivity, conformation and pharmacokinetic profiles of site-specific PEGylated thymosin alpha 1 derivatives.
    Qie J; Ma J; Wang L; Xu X; Zheng J; Dong S; Xie J; Sun H; Zhou W; Qi C; Zhao X; Zhang Y; Liu K
    Drug Metab Lett; 2007 Aug; 1(3):232-40. PubMed ID: 19356048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell abnormalities after mediastinal irradiation for lung cancer. The in vitro influence of synthetic thymosin alpha-1.
    Schulof RS; Chorba TL; Cleary PA; Palaszynski SR; Alabaster O; Goldstein AL
    Cancer; 1985 Mar; 55(5):974-83. PubMed ID: 3155644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.